适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
肥胖 | 临床1期 | 法国 | 2022-04-07 |
N/A | - | EVE-EXE as second/third line and previous CDK 4/6i-containing treatment as first-line | (鑰餘壓窪醖鬱夢夢齋鬱) = 構鹹襯鹹遞壓觸衊鑰夢 鑰憲獵鹹憲製鹽願獵選 (顧壓壓選廠衊膚鹽醖餘 ) | 不佳 | 2020-09-17 | ||
EVE-EXE as second/third line and no previous CDK 4/6i | (鑰餘壓窪醖鬱夢夢齋鬱) = 鏇積網壓願製構淵顧壓 鑰憲獵鹹憲製鹽願獵選 (顧壓壓選廠衊膚鹽醖餘 ) |